CJC-1295 Peptide: DAC vs No-DAC, GH Benefits & Stacking Explained (2026)

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate the pituitary to release more of your own growth hormone. It comes in two main versions with very different half-lives and dosing schedules.
In this video we cover:
• What CJC-1295 is and how it works on the GHRH receptor
• Critical difference between CJC-1295 with DAC (long-acting) and without DAC (Mod GRF 1-29, short-acting)
• How each version affects GH pulse patterns and IGF-1
• Potential benefits linked to elevated endogenous GH (sleep, recovery, body composition support)
• Human research data and evidence limitations
• Typical research dosing ranges for both versions
• Why it is most often stacked with Ipamorelin for synergistic GH release
• Safety notes and current research context
CJC-1295 aims to support natural growth hormone signaling rather than replacing it with exogenous HGH. It remains a research compound.
This is educational content only — not medical advice. Always consult a qualified healthcare provider.
If this clarified CJC-1295 for you, like, subscribe, and leave your questions below.
#CJC1295 #CJC1295Peptide #GrowthHormone #DAC #Ipamorelin #GHSecretagogue #Peptides